Safety and tolerability of fentanyl sublingual spray during the titration phase of two phase 3 clinical trials: results from pooled data

被引：0
|
作者：
Rauck, R. [1 ]
Stearns, L. [1 ]
Forman, N. [1 ]
Parikh, N. [1 ]
Dillaha, L. [1 ]
机构：
[1] INSYS Therapeut, Chandler, AZ USA
来源：
JOURNAL OF PAIN | 2014年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
365
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [41] Bimekizumab safety and tolerability in patients with moderate to severe plaque psoriasis: Analysis of pooled data from up to three years of treatment in five phase 3/3b clinical trials
    Gordon, Kenneth B.
    Gooderham, Melinda
    Foley, Peter
    Okubo, Yukari
    Warren, Richard B.
    Peterson, Luke
    Madden, Cynthia
    Szilagyi, Balint
    Deherder, Delphine
    Thaci, Diamant
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB22 - AB22
  • [42] The Safety and Tolerability of Rimegepant 75 mg Are Similar to Placebo: Results from 3 Phase 3 Trials in Adults With Migraine
    Hutchinson, S.
    Lipton, R. B.
    Thiry, A. C.
    BA, Morris
    Coric, V
    Croop, R.
    HEADACHE, 2019, 59 : 179 - 180
  • [43] Efficacy and safety of satralizumab for relapse prevention in neuromyelitis optica spectrum disorder: a pooled analysis from two Phase 3 clinical trials
    Yamamura, Takashi
    de Seze, Jerome
    Weinshenker, Brian G.
    Terada, Yusuke
    Kawata, Yuichi
    Gianella-Borradori, Athos
    von Budingen, Christian
    Klingelschmitt, Gaelle
    Traboulsee, Anthony
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP100 - NP101
  • [44] Efficacy and safety of satralizumab for relapse prevention in neuromyelitis optica spectrum disorder: a pooled analysis from two phase 3 clinical trials
    de Seze, J.
    Weinshenker, B. G.
    Terada, Y.
    Kawata, Y.
    Gianella-Borradori, A.
    von Budingen, C.
    Klingelschmitt, G.
    Traboulsee, A.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 904 - 905
  • [45] Efficacy of Dichlorphenamide in Primary Periodic Paralysis: Pooled-Data Analysis of Two Phase 3 Clinical Trials
    Shieh, Perry
    Cohen, Fredric
    Barohn, Richard
    Griggs, Robert
    NEUROLOGY, 2018, 90
  • [46] SAFETY AND TOLERABILITY OF PRUCALOPRIDE (RESOLOR) IN PATIENTS WITH CHRONIC CONSTIPATION: POOLED DATA FROM THREE PIVOTAL PHASE 3 STUDIES
    Tack, J.
    Kerstens, R.
    Ausma, J.
    Beyens, G.
    Vandeplassche, L.
    GUT, 2010, 59 : A141 - A142
  • [47] Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials
    Gallagher, Conor J.
    Bowsher, Ronald R.
    Clancy, Amanda
    Dover, Jeffrey S.
    Humphrey, Shannon
    Liu, Yan
    Prawdzik, Gregg
    TOXINS, 2023, 15 (01)
  • [48] Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trials
    Shapiro, Michael D.
    Taub, Pam R.
    Louie, Michael J.
    Lei, Lei
    Ballantyne, Christie M.
    ATHEROSCLEROSIS, 2023, 378
  • [49] Clinical data from Phase 3 trials in Pramlintide
    不详
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 1999, 15 (02) : 157 - 157
  • [50] Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials
    Gardiner, David
    Dukart, Gary
    Cooper, Angel
    Babinchak, Timothy
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (02) : 229 - 238
12345